Group One Trading’s scPharmaceuticals SCPH Stock Holding History

Group One Trading’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500	Closed	-$2.83K	–	9047
2025 Q3	$2.83K	Buy	+500	New	+$2.56K	﹤0.01%	7784
2024 Q2	–	Sell	-6,500	Closed	-$32.6K	–	7398
2024 Q1	$32.6K	Hold	6,500	–	–	﹤0.01%	5054
2023 Q4	$40.8K	Buy	6,500 +4,300	+195%	+$24.6K	﹤0.01%	5222
2023 Q3	$15.7K	Sell	2,200 -9,900	-82%	-$78K	﹤0.01%	6073
2023 Q2	$123K	Buy	+12,100	New	+$126K	﹤0.01%	4405
2023 Q1	–	Sell	-100	Closed	-$717	–	7872
2022 Q4	$717	Buy	+100	New	+$611	﹤0.01%	6901

Group One Trading's SCPH Position: Q4 2025 in Review

Group One Trading sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 15,630 shares — an estimated $88.6K sold.

Group One Trading first reported a position in SCPH in Q1 2022 and held it in 12 quarters. The position peaked at $291K in Q3 2024. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Group One Trading reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Group One Trading sold 15,630 scPharmaceuticals shares in Q4 2025, an estimated $88.6K.
Group One Trading first reported a position in scPharmaceuticals in Q1 2022 and held it in 12 quarters.
Group One Trading's scPharmaceuticals position peaked at $291K in Q3 2024.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.